Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Change in Inventory (2016 - 2025)

Dexcom (DXCM) has disclosed Change in Inventory for 16 consecutive years, with $17.8 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 154.43% to $17.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.7 million through Dec 2025, up 613.71% year-over-year, with the annual reading at $63.7 million for FY2025, 613.71% up from the prior year.
  • Change in Inventory for Q4 2025 was $17.8 million at Dexcom, down from $33.6 million in the prior quarter.
  • The five-year high for Change in Inventory was $78.6 million in Q3 2023, with the low at -$32.7 million in Q4 2024.
  • Average Change in Inventory over 5 years is $18.3 million, with a median of $18.2 million recorded in 2025.
  • The sharpest move saw Change in Inventory tumbled 223.96% in 2022, then soared 5136.36% in 2023.
  • Over 5 years, Change in Inventory stood at $6.0 million in 2021, then tumbled by 195.0% to -$5.7 million in 2022, then surged by 1135.09% to $59.0 million in 2023, then plummeted by 155.42% to -$32.7 million in 2024, then soared by 154.43% to $17.8 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $17.8 million, $33.6 million, and $18.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.